Publication | Open Access

Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine

VaccinationBnt162b2 VaccineVaccine DevelopmentMedicineImmunologyDomain AntibodiesClinical CharacteristicsVaccine ResearchViral ImmunityCovid-19